Tcelna

Imilecleucel-T · Opexa Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tcelna, covering 2017-01-10 to 2017-01-10. Get the full timeline:

Most recent: Clinical Trial Update: Study of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple Sclerosis [Phase 2]